Liposomal Vincristine in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma

NCT00006383 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: liposomal vincristine sulfate

Sponsor

Inex Pharmaceuticals